



Diversified Consumer Services | Small Cap
Nidan Laboratories & Healthcare Ltd demonstrates a mixed financial performance. The company exhibits strong solvency and profitability, suggesting a solid foundation. Its liquidity position is also reasonably good, indicating the company's ability to meet its short-term obligations. However, growth metrics and financial ratios reveal causes for concern, highlighting potential challenges in revenue and earnings sustainability. The company's efficiency needs improvement, particularly in fixed asset and capital turnover. While the company shows strengths in managing debt and generating profits, addressing the identified weaknesses is crucial for ensuring long-term financial health and stability.
Nidan Laboratories & Healthcare Ltd demonstrates a mixed financial performance. The company exhibits strong solvency and profitability, suggesting a solid foundation. Its liquidity position is also reasonably good, indicating the company's ability to meet its short-term obligations. However, growth metrics and financial ratios reveal causes for concern, highlighting potential challenges in revenue and earnings sustainability. The company's efficiency needs improvement, particularly in fixed asset and capital turnover. While the company shows strengths in managing debt and generating profits, addressing the identified weaknesses is crucial for ensuring long-term financial health and stability.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
12.18
Industry Median
53.17
Small Cap Median
50.07
P/E RATIO
12.06
P/B RATIO
0.26
Industry Median
5.27
Small Cap Median
3.62
P/S RATIO
0.72
Industry Median
3.91
Small Cap Median
2.08
Others
PEG RATIO
0.00
EV/EBITDA RATIO
3.18
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹13.15 as on Sep 1, 2026.
The growth ratios present a mixed picture of the company's performance. Revenue and asset growth is encouraging, suggesting expansion in operations and asset base. However, the negative Operating Profit Growth Rate, EPS Growth, and Net Income Growth Rate raise concerns about the sustainability of earnings. While the company is growing, its profitability is declining, which needs to be addressed for long-term viability.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 45.53 | -18.17 | -0.37 | 1.45 | 4.12 |
| Operating Profit Growth Rate | 5.85 | -27.74 | -5.29 | -21.43 | -4.35 |
| Earnings Per Share (EPS) Growth | -17.67 | 33.51 | -190.98 | 161.21 | -23.24 |
| Asset Growth Rate | 64.64 | -4.61 | -2.19 | 0.47 | 1.28 |
| Net Income Growth Rate | 15.65 | 33.08 | -191.24 | 161.3 | -23.74 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Nidan Laboratories & Healthcare Ltd | 6.32 | 12.06 | Neutral | 4.84 | 1.08 | 1.51 |
| 2 | Aatmaj Healthcare Ltd | 6.29 | 59.68 | Undervalued | 2.36 | 0.32 | 0.71 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Hour Timeframe
Analyzing moving average trends and crossovers. Green/Red badges indicate if the current condition passes or fails.
Comparing stock price performance (normalized) against benchmark indices over time.
Recent daily trading volume represented as a bar chart, alongside historical averages.
Current closing price relative to the 52-week highest and lowest prices.
No Stock Reports Available at This Moment.
Nidan Laboratories & Healthcare Ltd is a diagnostic healthcare service provider operating primarily in the Mumbai Metropolitan Region. The company offers a comprehensive range of pathology, radiology, and cardiology services through its network of laboratories and collection centers, focusing on affordable and accessible diagnostics.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Nidan Laboratories & Healthcare Ltd's P/E ratio (TTM) is 12.18, compared to the industry median of 53.17 and large cap median of 50.07.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Nidan Laboratories & Healthcare Ltd's P/B ratio is 0.26, compared to the industry median of 5.27 and large cap median of 3.62.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Nidan Laboratories & Healthcare Ltd's P/S ratio is 0.72, compared to the industry median of 3.91 and large cap median of 2.08.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Nidan Laboratories & Healthcare Ltd's PEG ratio is 1.80.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Nidan Laboratories & Healthcare Ltd's EV/EBITDA ratio is 3.18.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Nidan Laboratories & Healthcare Ltd's ROE is 2.17%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Nidan Laboratories & Healthcare Ltd's ROA is 5.76%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Nidan Laboratories & Healthcare Ltd's ROCE is 5.99%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Nidan Laboratories & Healthcare Ltd's operating margin is 18.95%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. Nidan Laboratories & Healthcare Ltd's net margin is 5.91%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Nidan Laboratories & Healthcare Ltd's current ratio is 4.59.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Nidan Laboratories & Healthcare Ltd's debt-to-equity ratio is 0.05.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Nidan Laboratories & Healthcare Ltd's interest coverage ratio is 2.24.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Nidan Laboratories & Healthcare Ltd's DPS is ₹0.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Nidan Laboratories & Healthcare Ltd's EPS is -23.24.
(Source line: "Ratios as of 10 Nov 2026, based on last traded price of ₹13.15. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Founded: 2012
Headquarters: Mumbai, Maharashtra
Core Offerings: Pathology services, Radiology & Imaging, Cardiology services, Health Check-ups, Home Collection
Stock Listing: NSE (NIDAN), BSE ({bse})
Promoter: Dr. Vijay Laxman Kulkarni & Family
Incorporated in 2012 in Mumbai, Nidan Laboratories & Healthcare Ltd commenced its operations with a focus on providing accessible diagnostic services. Over the years, the company has strategically expanded its network of diagnostic centers and collection points, enhancing its service portfolio to include a wide array of pathology, radiology, and cardiology tests, predominantly catering to the Mumbai Metropolitan Region.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| Pathology Services | Not specifically reported | Not specifically reported |
| Radiology & Imaging | Not specifically reported | Not specifically reported |
| Cardiology & Other Services | Not specifically reported | Not specifically reported |
Pathology Services: Offers a comprehensive suite of diagnostic tests including biochemistry, hematology, microbiology, and serology, facilitated by a robust network of collection centers and state-of-the-art laboratories.
Radiology & Imaging: Provides essential imaging services such as X-rays, sonography, ECG, and color doppler, crucial for accurate disease detection and monitoring.
Cardiology & Health Check-ups: Delivers basic cardiac diagnostic tests and various preventive health check-up packages designed for individual and corporate wellness.
Dr. Vijay Laxman Kulkarni - Managing Director & CEO. He is the founder of the company, steering its strategic vision and operational execution with extensive experience and expertise in the healthcare sector.
No major subsidiaries reported.
Bonus Issue in 2023 (1:1 ratio).
The Nidan Laboratories & Healthcare Ltd share price today is ₹13.15 on NSE (NIDAN), as of 10 Nov 2026.
As of 10 Nov 2026, Nidan Laboratories & Healthcare Ltd share price is ₹13.15, with previous close ₹13.15. Today's range is ₹13.15 to ₹13.15. The 52-week range is ₹N/A to ₹N/A.
As of today, Nidan Laboratories & Healthcare Ltd's market cap is ₹18.41 crore (Small Cap).
Nidan Laboratories & Healthcare Ltd's current P/E ratio is 12.18, compared to the DIVERSIFIED CONSUMER SERVICES sector average of 35.
Nidan Laboratories & Healthcare Ltd's current P/B ratio is 0.26.
Nidan Laboratories & Healthcare Ltd's current dividend yield is N/A. Last dividend of ₹0.30 per share was declared on 22-Sep-2023.
Nidan Laboratories & Healthcare Ltd's EPS (TTM) is ₹-23.24.
Nidan Laboratories & Healthcare Ltd is a diagnostic healthcare service provider operating primarily in the Mumbai Metropolitan Region. The company offers a comprehensive range of pathology, radiology, and cardiology services through its network of laboratories and collection centers, focusing on affordable and accessible diagnostics.
Nidan Laboratories & Healthcare Ltd is promoted by Dr. Vijay Laxman Kulkarni & Family, holding 57.04% as of 10 Nov 2026.
Nidan Laboratories & Healthcare Ltd is listed on NSE (NIDAN) and BSE ({bse}). Its next quarterly results are expected on August 2024.